Nearly 100 attendees gathered at Swedish Hospital in Seattle for a symposium featuring four of the most well respected leaders in the skin care industry. David Suzuki, President of Bio-Therapeutic, was joined by Rebecca James Gadberry, chairman and Co-CEO of YG Laboratories, Inc., Dr. Mark Lees, PH.D., M.S., President of Mark Lees Skin Care and Anne Martin, a licensed aesthetician and co-founder with Dr. Lees, of the Institute of Advanced Clinical Esthetics.
Mr. Suzuki spoke in depth about microcurrent, ATP, and cellular aging and how intelligent technology such as the Suzuki Sequencing™ adapts to genetic frequencies that are specific to each individual, increasing the synthesis of ATP and slows down the cellular aging process. The day included lectures by each speaker, notably topics such as causes of and time tested treatments for acne and problem skin, insights on what cosmetics and biochemists are doing to control and lessen the effects of inflammation in skin, and the fundamentals of the Aesthetic profession in showing empathy when relating with patients with problem skin.
For more information, call 800-971-6438 or visit www.bio-therapeutic.com.
Bio-Therapeutic, Inc., the world leader in anti-aging technology, was established in 1974, and is headquartered in Seattle, Washington. With over 20 distributors worldwide, Bio-Therapeutic supplies skin therapists with the most cutting edge, age defying technology available today including the Bio-Ultimate Platinum™ microcurrent system, Bio-Oxygen ™ oxygen infusion system, Bio-Brasion ™ microdermabrasion system, Bio-Dermology ™ cellulite system, and Bio-Synthesis™ light activated rejuvenation system. The company is a FDA and ISO registered device manufacturer, and all equipment is safety tested and UL/CSA listed.
